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A key focus of the health-related sus-
tainable development goal (SDG) 3 is 
universal health coverage (UHC), in-
cluding access to safe, effective, quality, 
and affordable essential medicines and 
vaccines. However, the challenges to 
achieving UHC are substantial, espe-
cially with increased demands on the 
health sector and with most budgets 
being static or shrinking.1
Immunization programmes have 
been successful in reaching children 
worldwide. For example, 86% of the 
world’s infants had received three doses 
of diphtheria-tetanus-pertussis (DTP3) 
vaccine in 2018.2 The experiences from 
such programmes can contribute to 
UHC, and as these programmes strive to 
adapt to new global strategic frameworks, 
such as Gavi, the Vaccine Alliance’s 
strategy Gavi 5.0 and the World Health 
Organization’s (WHO) Immunization 
Agenda 2030, these efforts can inform 
the progressive realization of UHC. Im-
munization programmes that can sustain 
regular levels of contact between health 
providers and beneficiaries at the com-
munity level have enabled new vaccines 
to be added to routine immunization 
schedules and other interventions to be 
delivered to children and their families. 
In addition, experiences from both polio 
campaigns and the child health days 
strategy show that incorporating addi-
tional interventions into campaigns can 
increase coverage of these interventions 
as well as of vaccinations.3,4
Improving immunization 
coverage
Considering how to expand integration 
efforts and to better focus immunization 
on the most disadvantaged, including 
attention to addressing social deter-
minants of health, will be critical for 
further progress. The Equity Reference 
Group for Immunization has conducted 
analyses based on published and un-
published literature, as well as a series 
of interviews with experts working at 
global, national and community levels 
to highlight several related challenges 
and opportunities. Here we discuss 
challenges and opportunities related 
to data quality, vertical immunization 
programmes, underserved children 
and gender.
In 2018, 19.4 million children 
younger than one year of age did not 
receive DTP3, and approximately 41% 
of these children live in countries that 
are polio-endemic, fragile or affected 
by conflict.2 In addition, a growing 
share of children live in middle-income 
countries where vulnerability and social 
exclusion, particularly among the urban 
poor, prevents many from receiving 
vaccination. Children living in remote 
rural areas, although long identified as 
a target population for immunization 
programmes, continue to be under-
served. Furthermore, immunization 
programmes often ignore inequities 
caused by bias and discrimination in 
response to the social constructs of 
ethnicity and gender.
Data quality
There is growing evidence on the rea-
sons these inequities in immunization 
exist and how to address them. Acting 
on this evidence is the challenge to 
increasing coverage, particularly as it 
will require redistributing resources, 
prioritizing those who are often subject 
to discrimination and operating in chal-
lenging contexts. Currently, opportuni-
ties that are important considerations 
for immunization decision-makers and 
implementers exist.
The first opportunity is the im-
provement of data quality and use of 
both traditional surveys and new tech-
nologies. Approaches such as linking 
data sets and use of electronic health 
information systems can facilitate re-
cording and reporting of real-time data. 
Simple analyses using existing data can 
also help us better understand key equity 
issues within countries. For example, in 
2018, WHO released an equity analysis 
of ten countries that Gavi has identified 
as the highest priority for childhood 
immunization.5 Using Demographic 
and Health Surveys (DHS), the report 
presents disaggregated data on, and as-
sociations with, DTP3 coverage by key 
characteristics of children, mothers and 
households. This type of information 
can serve as a basis for more detailed 
explorations at both national and sub-
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national levels, and as a baseline for 
future efforts to redress equity gaps. 
New technologies can provide a better 
user interface and geospatial informa-
tion gathering, particularly to improve 
traditional survey methods and tools. 
Such advances would facilitate new op-
portunities that big data and artificial 
intelligence approaches are bringing to 
public health.
The second opportunity is innova-
tions such as machine learning and use 
of satellite imagery, which are already 
improving estimates of how many chil-
dren live in different geographic areas, 
and supporting better visualization 
of data, which health workers can act 
upon. Polio eradication programming, 
for example, has shown how the use 
of granular data through geographic 
information systems mapping, coupled 
with surveillance data, can identify 
children who are hard to reach by the 
health-care system. Predictive models 
informed by data across sectors, such 
as health, protection, transport and tele-
communications, could identify pockets 
of low coverage even where surveys 
have not been conducted. However, as 
quality data are only relevant if used at 
local levels for planning and budgeting, 
capacity must be built at national and 
sub-national levels to better use these 
data to adapt and expand service de-
livery strategies. These transformative 
investments will be critical for both 
immunization programming and UHC, 
even as discussions of how best to mea-
sure UHC continue.
Vertical programmes
The vertical nature of immunization 
programmes is a challenge. This orga-
nizational structure has enabled robust 
vaccination gains, but has been imple-
mented without enough attention to 
how immunization assets can be used 
more broadly. Identifying the right mix 
of interventions to integrate with im-
munization services, informed by cost–
benefit and cost–effectiveness analyses, 
is critical to ensure that integration 
does not overburden health workers or 
negatively impact coverage and quality.4 
At the global level, additional research is 
needed to further develop an evidence 
base around new service delivery mod-
els and innovations to simplify vaccine 
delivery for all children, particularly 
those living in difficult-to-reach areas. 
Experts point to the success of strategies 
that use meticulous microplanning to 
identify the unreached, engage com-
munities and improve reach through 
public-private partnerships. Indeed, 
one of the core axes of UHC is that 
communities own and drive the design 
and implementation of services. Immu-
nization programmes are well placed to 
support this, building on the strengths 
of the WHO’s Reaching Every District 
approach, which includes community 
engagement as a cornerstone. In addi-
tion, needle-free vaccine administration 
and thermo-stable vaccines are promis-
ing innovations to enable the health 
system to simplify and expand delivery 
to marginalized children. Adoption 
of novel strategies, such as optimizing 
delivery strategies and doses per con-
tainer, reduced dosages and adapted 
target age ranges within campaigns may 
reduce disease burden in displaced and 
intermittently accessible populations. 
Furthermore, the rollout of human 
papillomavirus (HPV) vaccination in 
many countries presents new opportuni-
ties for reaching adolescents with other 
services, such as screening programmes 
and treatment or other vaccines, and 
provision of information and life skills. 
This increased reach can facilitate access 
for adolescents and can reduce costs and 
burdens related to delivering interven-
tions separately.
Underserved children
Developing better approaches for chil-
dren who may be accessible geographi-
cally, but who remain underserved is 
also a challenge. In some cases, children 
are underserved by commission, that is, 
their families deliberately avoid vaccina-
tion, while others by omission due to 
a variety of service delivery and social 
factors leading to intentional or uninten-
tional exclusion. Incorporating the latest 
thinking around effective behaviour 
change approaches into programme and 
communication strategies may provide 
new opportunities to reach these chil-
dren. Reaching these children will also 
require health systems strengthening, 
improved quality of care, intersectoral 
and intragovernmental collaboration, 
and new emphasis on social justice, non-
discrimination, civil society engagement 
and accountability, among other efforts.6
Gender
A final challenge is to ensure that gender 
is recognized as a critical, cross-cutting, 
and influencing factor, and ensuring 
that gender analyses of immunization 
are not restricted to comparing cover-
age outcomes between boys and girls. 
Studies show that maternal education 
and maternal age are key determinants 
of whether a child is immunized. As 
well, the agency and empowerment of 
women, and women’s access to qual-
ity services can affect the likelihood 
of childhood immunization.7 We must 
identify and test ways in which im-
munization programmes can mitigate 
gender-related barriers without under-
mining, but rather ideally contributing 
to, women’s empowerment in different 
settings. HPV vaccination raises addi-
tional gender and equity considerations, 
particularly as services for adolescents 
can be quite limited in both availability 
and quality in many settings.8
Addressing inequities
The strategic importance, effectiveness 
and cost–effectiveness of focusing on the 
poorest and hardest-to-reach children 
has been emphasized before.9,10 Equity 
in immunization may also contribute 
to building solidarity within countries 
for UHC, as everyone, across all so-
cioeconomic levels and from a variety 
of backgrounds, will benefit from 
increased herd immunity. However, 
building solidarity for social and health 
programmes can be a key challenge in 
settings where the more advantaged 
people question why they should pay 
taxes to ensure services for the less 
advantaged.11 Fortunately, immuniza-
tion programmes are an example of a 
public good which, when strengthened 
and expanded, will benefit those same 
tax-payers, while also benefitting those 
who have been previously denied this 
essential intervention. The financial re-
turn on investment in vaccines has been 
found to be up to 44 times their cost.12
We must address inequities in im-
munization not just for the obvious 
health, financial and political benefits 
that come from herd immunity and 
absence of disease, but because without 
greater achievement in immunization 
among children living in urban poor, 
remote rural or conflict settings, it will 
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be impossible to collectively reach our 
shared goals for primary health care 
and UHC.
We have highlighted some of the 
innovations in the field, as well as the 
existing assets that immunization pro-
grammes can bring. However, using 
the full potential of immunization pro-
grammes to advance UHC will require 
strategic changes, such as increased 
efforts to integrate with other services 
and reaching children never reached by 
the health system. ■
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